Innovation

The Human Serotonin Transporter Gene (SLC6A4) is a Susceptibility Locus for Autism, Harbors Heterogeneous Functionally-Abnormal Alleles, and Confers Genetic Risk for Autism Spectrum Disorders in a Male-Biased Fashion

Vanderbilt University
posted on 01/25/2010

-


Innovation Details
 

Detailed Description

Autism spectrum disorders are common and are reported to have a population prevalence of ~1/300- 1/500. The Sutcliffe laboratory, in collaboration with the Blakely laboratory, has identifi ed the serotonin transporter gene (gene symbol: SLC6A4; protein: hSERT) as being a genetic risk locus for autism and autism spectrum disorders. This would represent the first autism gene to be described in which functionally abnormal alleles confer genetic risk for this common developmental disorder. Based on our current findings, this gene appears to confer risk that affects a signifi cant number of families with autism and related traits.

Supplemental Documents
VU0561—Allelic Variation in the Serotonin Transporter as an Indicator of Autism


Inventors
Randy Blakely
Nicholas Campbell
Ryan Delahanty
Tammy Jessen
Harish Prasad
James Sutcliffe
Jeremy Veenstra-Vander Weele
Chong-Bin Zhu


CONTACT
Karen Rufus
(615) 322-4295
karen.rufus@vanderbilt.edu

File Number: MKT0561  


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Karen Rufus at Vanderbilt University for more information.

Request more info via email request more info
People

Case Manager:

Karen Rufus Karen Rufus

Innovations (20)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...